Pyrazole is a nitrogen-containing five-membered heterocyclic compound,
where nitrogen atoms are positioned at positions 1 and 2 within the
ring. Acridine, a nitrogen-containing polycyclic aromatic compound. This
study aimed to synthesize a novel pyrazole-acridine derivative,
combining the structural elements of pyrazole and acridine into a single
molecule, with the objective of enhancing its anticancer activity. The
pyrazole-4-carbaldehyde derivative was cyclized with
5,5-dimethylcyclohexane-1,3-dione and 4-nitroaniline to synthesize the
pyrazole-acridine derivative (3-ACH). Characterization of the compound
FT-IR, NMR, HPLC-Q-Tof/MS and elemental analysis were used. In our
investigation, we assessed the cytotoxic impact of 3-ACH on SH-SY5Y
human neuroblastoma cells in a dose-dependent manner (50, 100, and 150
μg/mL) and in a time-dependent (12, 24, and 48hours) manner using the
WST-1 test. The effects of 3-ACH on apoptosis were examined through
immunostaining of BAX, Caspase-3, Caspase-8, Caspase-9 proteins. The
results showed that the cytotoxicity of 3-ACH increased with doses and
exposure times. Moreover, we observed a significant upregulation in the
synthesis of BAX, Caspase-3,-8,-9 proteins. These findings suggest that
3-ACH has the potential to induce apoptosis in SH-SY5Y cells by
activating both the intrinsic and extrinsic pathways, which may
contribute to its cytotoxic effects. Our study supports 3-ACH as a
promising anticancer agent.